Stage
IPO | IPOTotal Raised
$216.62MDate of IPO
6/19/2020Market Cap
0.26BStock Price
1.69About Progenity
Progenity is a biotechnology company with a presence in women's health molecular testing and a pipeline of proprietary tests and therapeutic applications. Progenity has a portfolio of technologies and tests for pre-eclampsia, genetic carrier testing, inheritable cancer genetics, liquid biopsy and noninvasive prenatal testing (NIPT), all designed to support clinicians in providing excellent patient care.
Progenity Headquarter Location
4330 La Jolla Village Drive Suite 200
San Diego, California, 92122,
United States
855-293-2639
Latest Progenity News
Jan 11, 2022
The abstract is now available on the BWGE 2022 website . About Progenity Progenity, Inc. is a biotechnology company innovating in the fields of women’s health, gastrointestinal health and oral biotherapeutics. Progenity applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies. For more information visit www.progenity.com , or follow the company on LinkedIn or Twitter . Investor Contact:
Expert Collections containing Progenity
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Progenity is included in 5 Expert Collections, including Women's Health & Wellness.
Women's Health & Wellness
1,445 items
Startups focused on providing products and services catering to women's health and wellbeing.
Medical Devices
7,889 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Health Monitoring & Diagnostics
2,394 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Omics
1,213 items
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
Progenity Patents
Progenity has filed 51 patents.
The 3 most popular patent topics include:
- Gastrointestinal tract disorders
- Histopathology
- Digestive system
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/15/2021 | 11/30/2021 | Molecular biology, Genetics, Transcription factors, DNA, Rare diseases | Grant | |
Application Date | 1/15/2021 | ||||
|---|---|---|---|---|---|
Grant Date | 11/30/2021 | ||||
Title | |||||
Related Topics | Molecular biology, Genetics, Transcription factors, DNA, Rare diseases | ||||
Status | Grant |
